Drug Shortage Report for TIMOPTIC
| Report ID | 230791 |
| Drug Identification Number | 00451207 |
| Brand name | TIMOPTIC |
| Common or Proper name | timolol maleate |
| Company Name | ELVIUM LIFE SCIENCES |
| Market Status | MARKETED |
| Active Ingredient(s) | TIMOLOL |
| Strength(s) | 0.5% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 10ml |
| ATC code | S01ED |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-06-17 |
| Actual start date | 2024-06-17 |
| Estimated end date | 2025-04-25 |
| Actual end date | 2025-04-24 |
| Shortage status | Resolved |
| Updated date | 2025-04-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.